2014. ISPOR European Congress – PRO Claims in Orphan Medicines Approved by the European Medicines Agency (EMA) for the Treatment of Lymphoproliferative Disorders

Acquadro C, Perret C, Arnould B. PRO Claims in Orphan Medicines Approved by the European Medicines Agency (EMA) for the Treatment of Lymphoproliferative Disorders. Value Health. 2014 Nov;17(7):A536. Presented at: ISPOR 17th Annual European Congress; November 11, 2014; Amsterdam, The Netherlands.